IMUNON, Inc. (IMNN) Reports Q3 Loss of $3.8M, Versus $3.4M a Year Earlier

IMUNON reported Q3 2026 net loss of $3.8M ($0.64 per share), versus $3.4M ($1.16 per share) in Q3 2025. At September 30, cash and cash equivalents were $4.0M, plus $5.0M of restricted cash.Material DetailsContext by AI AnalystThe results come as IMUNON advances its lead candidate in a Phase 3 ovari…